A Novel Dysferlin-Binding Kinase CK2α Promotes Plasma Membrane Repair in Dysferlinopathy

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Medicine

Background:

• Dysferlinopathy is an autosomal recessive muscular dystrophy linked to mutations in the dysferlin gene.
• Dysferlin is crucial for plasma membrane repair, but its signaling pathways and interactions are not fully understood.
• The region between dysferlin's C2 domains 3 and 4 is a hotspot for mutations and contains key functional domains.

Purpose of the Study:

• To identify novel dysferlin-binding proteins and elucidate their role in membrane repair.
• To investigate the function of protein kinase CK2α (formerly casein kinase 2) in relation to dysferlin.
• To explore the molecular mechanisms underlying plasma membrane repair involving dysferlin, CK2α, and annexin A1.

Main Methods:

• Identification of CK2α as a novel dysferlin-binding protein using biochemical approaches.
• Analysis of CK2α localization at membrane injury sites in mouse skeletal muscle.
• Assessment of membrane repair in CK2α knockout cells and dysferlin-deficient muscle with CK2α overexpression.
• Investigation of CK2α's role in phosphorylating annexin A1.

Main Results:

• CK2α was identified as a novel dysferlin-binding protein and co-localized with dysferlin at membrane injury sites.
• CK2α knockout cells exhibited delayed membrane repair, while CK2α overexpression improved repair in dysferlin-deficient muscle.
• CK2α was found to phosphorylate annexin A1, a known dysferlin-binding protein involved in membrane repair.

Conclusions:

• CK2α plays a critical role in controlling plasma membrane repair through the phosphorylation of annexin A1.
• The interaction between dysferlin, CK2α, and phosphorylated annexin A1 represents a potential therapeutic strategy for enhancing membrane repair.
• This study uncovers a novel molecular mechanism and therapeutic target for dysferlinopathies.